$MYNZ - Mainz Biomed recently announced it has successfully completed the pre-submission process with the U.S FDA for its ColoAlert Pivotal Clinical Trial. https://www.l3opptrk.com/3J67C1/3T3PPKJ/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.